161 related articles for article (PubMed ID: 6600482)
1. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
Hartung HP; Bitter-Suermann D; Hadding U
J Immunol; 1983 Mar; 130(3):1345-9. PubMed ID: 6600482
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of prostaglandin E and thromboxane synthesis in macrophages by purified C3b.
Hartung HP; Hadding U; Bitter-Suermann D; Gemsa D
J Immunol; 1983 Jun; 130(6):2861-5. PubMed ID: 6343486
[TBL] [Abstract][Full Text] [Related]
3. Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H.
Hartung HP; Hadding U; Bitter-Suermann D; Gemsa D
Clin Exp Immunol; 1984 May; 56(2):453-8. PubMed ID: 6234114
[TBL] [Abstract][Full Text] [Related]
4. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
Kreuzpaintner G; Damerau B; Zimmermann B; Plummer TH; Brade V
J Immunol; 1986 May; 136(9):3384-9. PubMed ID: 3485689
[TBL] [Abstract][Full Text] [Related]
6. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of macrophage oxygen metabolism on immobilized ligands: different effect of immunoglobulin G and complement.
Valletta EA; Berton G
J Immunol; 1987 Jun; 138(12):4366-73. PubMed ID: 2953806
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
Hoffmann T; Böttger EC; Baum HP; Messner M; Hadding U; Bitter-Suermann D
Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
[TBL] [Abstract][Full Text] [Related]
9. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
Meuer S; Becker S; Hadding U; Bitter-Suermann D
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
[TBL] [Abstract][Full Text] [Related]
10. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
11. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.
Haeffner-Cavaillon N; Cavaillon JM; Laude M; Kazatchkine MD
J Immunol; 1987 Aug; 139(3):794-9. PubMed ID: 3496391
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
14. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
15. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
[TBL] [Abstract][Full Text] [Related]
16. Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a.
Püschel GP; Hespeling U; Oppermann M; Dieter P
Hepatology; 1993 Dec; 18(6):1516-21. PubMed ID: 8244278
[TBL] [Abstract][Full Text] [Related]
17. Effects of activated complement components on enzyme secretion by macrophages.
Schorlemmer HU; Allison AC
Immunology; 1976 Nov; 31(5):781-8. PubMed ID: 992710
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
19. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
